Effect of thromboxane synthetase inhibitors on platelet function: Enhancement by inhibition of phosphodiesterase
- 1 November 1982
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 28 (4) , 477-485
- https://doi.org/10.1016/0049-3848(82)90164-5
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Comparison of sulfinpyrazone and BL-3459 with S - 20344, a potent new antithrombotic agentThrombosis Research, 1981
- A potent new inhibitor of platelet aggregation and experimental thrombosis, anagrelide (BL-4162A)Thrombosis Research, 1979
- Effects of prostacyclin (PGX) on cyclic AMP concentrations in human plateletsProstaglandins, 1977
- Modulation of human platelet adenylate cyclase by prostacyclin (PGX)Prostaglandins, 1977
- Biosynthesis of prostaglandin D2 1. Formation of prostaglandin D2 by human plateletsProstaglandins, 1977
- Metabolism of [14C]arachidonic acid by human plateletsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1976
- Stimulation of human platelet adenylate cyclase by prostaglandin D2Thrombosis Research, 1974
- Formation of Prostaglandins during the Aggregation of Human Blood PlateletsJournal of Clinical Investigation, 1973
- Platelet aggregation IV. Platelet phosphodiesterase and its inhibition by vasodilatorsBiochemical and Biophysical Research Communications, 1971
- Adenyl cyclase activity in human plateletsBiochemical and Biophysical Research Communications, 1969